Alan B

Alan B is a seasoned professional in regulatory affairs and medicinal chemistry, currently serving as the Regulatory Affairs Director at AstraZeneca since 2018, where they provide strategic insights and lead global regulatory efforts. Previously, Alan held positions including Senior Manager at Taiho Pharmaceutical Co., Ltd., and Senior Consultant at Clinical Network Services Pty Ltd. With extensive experience across various pharmaceutical companies, including GlaxoSmithKline and PAREXEL, they have contributed to drug development and regulatory strategies for oncology products and innovative therapies. Alan completed a PhD in Organic Chemistry at Imperial College London and a BSc in Chemistry and Biochemistry at Southampton University.